Recombinant human insulin (Nutrinia)

重组人胰岛素 (Nutrinia)

Report date: 2026/05/09 20:00:18

Base Information

Drug NameRecombinant human insulin (Nutrinia)
Drug Alias NameNTRA-9620
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonistsInsulin ligand
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNutrinia Inc
China Registration ClassN/A

Develop Information

Active CompaniesIsrael Oramd Co LtdHefei Haimai Tongheng Biological Technology Co LtdClinical Supplies Management Holdings Inc +[4] 
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A